Skip to Main content Skip to Navigation
New interface
Journal articles

Diffuse large B-cell lymphoma response rituximab-PMitCEBO regimen is not predicted by FcγRIIa158 polymorphism

Cristina Bagacean 1, 2, 3, 4 Naelle Lombion 5 Adrian Tempescul 3, 5, 1 Jean-Christophe Ianotto 5 Christian Berthou 3, 5, 1 Mihnea Zdrenghea 2, 4 Victor Cristea 2 
1 LabEX IGO Immunothérapie Grand Ouest
2 Iuliu Hatieganu University of Medicine and Pharmacy Cluj-Napoca
3 EA2216 - Immunologie et Pathologie
4 “Prof. Dr. Ion Chiricuta” Oncologic Insitute Cluj-Napoca
5 Department of Clinical Hematology, Institute of Cancerology and Hematology
Document type :
Journal articles
Complete list of metadata
https://hal.univ-brest.fr/hal-01260185
Contributor : Geneviève Michel Connect in order to contact the contributor
Submitted on : Thursday, January 21, 2016 - 4:11:10 PM
Last modification on : Wednesday, September 7, 2022 - 11:32:04 AM

Identifiers

  • HAL Id : hal-01260185, version 1

Collections

UNIV-BREST | IMMUNO

Citation

Cristina Bagacean, Naelle Lombion, Adrian Tempescul, Jean-Christophe Ianotto, Christian Berthou, et al.. Diffuse large B-cell lymphoma response rituximab-PMitCEBO regimen is not predicted by FcγRIIa158 polymorphism. Human & Veterinary Medecine Bioflux, 2015, 7 (4), pp.298-301. ⟨hal-01260185⟩

Export

BibTeX TEI DC DCterms EndNote Datacite

Share

Metrics

Record views

51